Upstream Bio
UPB· Manufacturing· Fiscal year ends in December
CEO pay in FY2025Stock +65.1% in FY2025
E. Rand Sutherland, M.D. is the CEO of Upstream Bio and was paid $4.3M in FY2025 (Dec), down 53%.
Pay$100 in the stock at the end of FY24 → $165
Executives3
See all- 1E. Rand Sutherland, M.D.Chief Executive OfficerFY2025
- 2Michael Paul Gray, M.B.A.Chief Financial Officer and Chief Operating OfficerFY2025
- 3Aaron Deykin, M.D.Chief Medical Officer and Head of Research and DevelopmentFY2025
Named executives and their total pay, from the Summary Compensation Table of the latest proxy.
Pay
See allUpstream Bio paid its 3 named executives $8.1M in total in FY2025 (Dec). CEO E. Rand Sutherland, M.D. was paid $4.3M of that.
| Name | |||
|---|---|---|---|
| E. Rand Sutherland, M.D.Chief Executive Officer | Not disclosed | ||
| Michael Paul Gray, M.B.A.Chief Financial Officer and Chief Operating Officer | Not disclosed | ||
| Aaron Deykin, M.D.Chief Medical Officer and Head of Research and Development | Not disclosed | Not disclosed |
of each named executive, from the Summary Compensation Table of each proxy.
Peers
No disclosed peer group
No proxy on file names a pay peer group for Upstream Bio. The peer group comes from the proxy statement, so it shows here when a proxy read has it.
Activity
Filings4
See all| Proxy statement | DEF 14A | Apr 16, 2026 | FY2025 |
| Annual report | 10-K | Mar 26, 2026 | FY2025 |
| Proxy statement | DEF 14A | Apr 17, 2025 | FY2024 |
| Annual report | 10-K | Mar 12, 2025 | FY2024 |
